Leiden University Medical Center or LUMC is the university hospital affiliated with Leiden University, of which it forms the medical faculty. It is located in Leiden, Netherlands. LUMC is a modern university medical center for research, education and patient care.

During the past decade, Leids Universitair Medisch Centrum conducted 190 clinical trials. In the 10-year time frame, 190 clinical trials started and 44 clinical trials were completed, i.e. on average, 23.2% percent of trials that started reached the finish line to date. In the past 5 years, 97 clinical trials started and 35 clinical trials were completed. i.e. 36.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leids Universitair Medisch Centrum" #1 sponsor was "Leiden University Medical Center" with 18 trials, followed by "The Netherlands Cancer Institute" with 15 trials sponsored, "Radboud University Medical Center" with 12 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 11 trials sponsored and "Hoffmann-La Roche" with 11 trials sponsored. Other sponsors include 191 different institutions and companies that sponsored additional 121 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leids Universitair Medisch Centrum" #1 collaborator was "Leiden University Medical Center" with 22 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 16 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 11 trials as a collaborator, "Erasmus Medical Center" with 10 trials as a collaborator and "Dutch Cancer Society" with 9 trials as a collaborator. Other collaborators include 245 different institutions and companies that were collaborators in the rest 186 trials.

According to Clinical.Site data, the most researched conditions in "Leids Universitair Medisch Centrum" are "Breast Cancer" (11 trials), "Duchenne Muscular Dystrophy" (10 trials), "Ulcerative Colitis" (7 trials), "Colorectal Cancer" (6 trials) and "Melanoma" (6 trials). Many other conditions were trialed in "Leids Universitair Medisch Centrum" in a lesser frequency.

Most popular intervention types in "Leids Universitair Medisch Centrum" are "Drug" (170 trials), "Other" (47 trials), "Device" (16 trials), "Procedure" (16 trials) and "Biological" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "placebo" (7 trials), "Atezolizumab" (4 trials), "Capecitabine" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Leids Universitair Medisch Centrum" are 216 trials for "All" genders, 25 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 117 active trials in "Leids Universitair Medisch Centrum". 2 are not yet recruiting, 76 are recruiting, 35 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 106 completed trials in Leids Universitair Medisch Centrum, undefined suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Leids Universitair Medisch Centrum, 23 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 38 trials that are defined as “Not Applicable".

Leids Universitair Medisch Centrum has several departments that took part in Clinical trials: "Leids Universitair Medisch Centrum; Cardiology" - 4 trials, "Department of Clinical Oncology, Leiden University Medical Center" - 4 trials, "Department of Pulmonology, Leiden University Medical Center" - 3 trials, "Academisch Ziekenhuis Leiden; Dept of Rheumatology" - 3 trials, "Leiden University Medical Center, Department of Neurology" - 2 trials, "Leids Universitair Medisch Centrum/ Klinische Oncologie" - 2 trials